Related Experiment Video

Updated: Jul 14, 2026

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

STAT1 and STAT3 as intracellular regulators of vascular remodeling

Andrzej Wincewicz1, Mariola Sulkowska, Ryszard Rutkowski

  • 1Department of Pathology, Waszyngtona St 13, 15-269 Białystok, Collegium Pathologicum, Medical University of Bialystok, Poland.

European Journal of Internal Medicine
|June 19, 2007
PubMed

Insights

Signal transducers and activators of transcription (STAT) proteins, particularly STAT1 and STAT3, play key roles in cardiovascular disease pathogenesis. Targeting these STAT proteins may offer a novel therapeutic strategy for anti-atherogenic therapy.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Inflammation Research

Background:

  • Signal transducers and activators of transcription (STAT) proteins are implicated in cardiovascular disease pathogenesis.
  • STAT1 and STAT3 activation is likely involved in atheromatous plaque proliferation and inflammation.

Purpose of the Study:

  • To review the roles of STAT1 and STAT3 proteins in vascular remodeling.
  • To explore STAT proteins as potential targets for anti-atherogenic therapy.

Main Methods:

  • Literature review of studies on STAT1 and STAT3 in cardiovascular diseases.
  • Analysis of STAT protein involvement in endothelial dysfunction and vascular cell signaling.
  • Examination of STAT protein interactions with pro-atherogenic factors and anti-apoptotic genes.

Main Results:

  • STAT1 activation contributes to endothelial thrombogenicity via MHC II induction.
  • STAT3 activation mediates vascular cell responses to growth factors (VEGF, HGF, Ang II) and promotes anti-apoptosis.
  • Statins may modulate STAT protein activity, suggesting therapeutic potential.

Conclusions:

  • STAT1 and STAT3 are critical mediators in the development of atherosclerosis.
  • Modulation of STAT1 and STAT3 signaling pathways presents a promising avenue for anti-atherogenic drug development.

More Related Videos

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro08:28

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro

Published on: February 15, 2022

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...